Medtronic unveils restructuring plan

Published On 2018-01-11 04:15 GMT   |   Update On 2018-01-11 04:15 GMT

Medtronic Plc on Monday unveiled a restructuring plan that it expects will help it save $500 million to $700 million annually over the next five years.


The company said it expected annual gross run-rate savings of over $3 billion by 2022 from the program.


The company also said it expected total expenses from the restructuring to be at between $1.6 billion and $1.8 billion from 2018 to 2022.


The plan was announced during a presentation at the J.P. Morgan Healthcare Conference.


Chief Executive Omar Ishrak said the company was confident about mid-single digit revenue growth in the short term.


Medtronic said in November it expected revenue growth to be in the range of 4-5 percent in fiscal 2018, and adjusted earnings to increase 9 to 10 percent.


Evercore ISI analyst Vijay Kumar said investors had been skeptical about the forecast, given industry trends in the first half of the year.


(Reporting by Manas Mishra in Bengaluru; Editing by Maju Samuel)

Article Source : REUTERS

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News